Arrhythmia Research Technology Shares Down 24.0% Since SmarTrend's Sell Call (HRT)

SmarTrend identified a Downtrend for Arrhythmia Research Technology (AMEX:HRT) on March 18th, 2015 at $6.76. In approximately 10 months, Arrhythmia Research Technology has returned 23.96% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.